News
-
-
-
-
-
PRESS RELEASE
Corrected press release : THX Pharma and the Beyond Batten Disease Foundation Announce the Grant of a European Patent Protecting the Use of Batten-1 in Juvenile Batten Disease (CLN3)
THX Pharma and Beyond Batten Disease Foundation secure European patent EP 4 188 371 for Batten-1 in juvenile Batten disease (CLN3), reinforcing long-term exclusivity strategy -
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Deutsche Börse AG: Deutsche Börse AG launches an offering of convertible bonds in an aggregate amount of EUR 600 million due 2031
Deutsche Börse AG launches EUR 600 million convertible bonds offering due 2031. Bonds will be convertible into shares or repaid in cash. Terms to be finalized later